Covered recipient · General Payments record
THAIR T DAWOOD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2022
$817.94
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.89 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $46.58 | 3 |
| Janssen Biotech, Inc. | $42.09 | 2 |
| Cepheid | $32.39 | 2 |
| Acerta Pharma LLC | $31.32 | 2 |
| ViiV Healthcare Company | $19.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $16.09 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915859665 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.23 | 06/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915487853 | CMS |
| Cepheid | $17.15 | 05/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960453827 | CMS |
| Cepheid | $15.24 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960453871 | CMS |
| Gilead Sciences, Inc. | $13.15 | 04/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929600403 | CMS |
| Gilead Sciences, Inc. | $17.26 | 07/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929600407 | CMS |
| Gilead Sciences, Inc. | $16.17 | 09/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 929600405 | CMS |
| Janssen Biotech, Inc. | $18.21 | 08/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886031423 | CMS |
| Janssen Biotech, Inc. | $23.88 | 09/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886031427 | CMS |
| ViiV Healthcare Company | $19.51 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 943983807 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.